Skip to main content

Table 4 mRNA-191 and miRNA-24 expression levels in the different study groups and healthy controls

From: The significance of miRNA-191-5P and miRNA-24-3P as novel biomarkers for multiple sclerosis: a case–control study

 

All MS (n = 80)

RRMS (n = 68)

Progressive MS (n = 12)

Healthy control (n = 40)

miRNA-191

1.01 (0.0058–1601.27)

(0.0058–1601.27

0.85 (0.0060–32)

1 (0–2076.59)

miRNA-24

2.38 (0.0002–680.29)

2.38 (0.0083–680.29)

1.99 (0.0002–49.18)

1 (0.0439–179.77)

  1. All data are presented as median (min.−max.)
  2. *Fold change formula: Fold−change=2 –ΔΔCT